News
HAE
57.64
+0.24%
0.14
Haemonetics Releases 2024-2025 Corporate Responsibility Report
TipRanks · 7h ago
Analysts’ Top Healthcare Picks: Haemonetics (HAE), Waters (WAT)
TipRanks · 2d ago
Weekly Report: what happened at HAE last week (0202-0206)?
Weekly Report · 3d ago
Haemonetics Earnings Call: Strong Core, IVT Drag
TipRanks · 5d ago
Haemonetics (HAE) Margin Strength In Q3 2026 Reinforces Earnings Led Bullish Narratives
Simply Wall St · 5d ago
Haemonetics Price Target Cut to $75.00/Share From $88.00 by Citigroup
Dow Jones · 6d ago
Haemonetics Is Maintained at Neutral by Citigroup
Dow Jones · 6d ago
These Analysts Revise Their Forecasts On Haemonetics After Q3 Earnings
Benzinga · 6d ago
Haemonetics price target lowered to $81 from $99 at Baird
TipRanks · 6d ago
Haemonetics Is Maintained at Outperform by Mizuho
Dow Jones · 6d ago
Haemonetics Price Target Cut to $80.00/Share From $90.00 by Mizuho
Dow Jones · 6d ago
Mizuho Maintains Outperform on Haemonetics, Lowers Price Target to $80
Benzinga · 6d ago
Haemonetics Is Maintained at Outperform by Barrington Research
Dow Jones · 6d ago
Haemonetics Price Target Raised to $94.00/Share From $93.00 by Barrington Research
Dow Jones · 6d ago
Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $94
Benzinga · 6d ago
Haemonetics price target lowered to $80 from $90 at Mizuho
TipRanks · 6d ago
Haemonetics price target raised to $94 from $93 at Barrington
TipRanks · 6d ago
Haemonetics (HAE) Valuation Check After Q3 Beat And Higher 2026 Guidance
Simply Wall St · 6d ago
Haemonetics price target lowered to $75 from $88 at Citi
TipRanks · 6d ago
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Haemonetics (HAE) and Denali Therapeutics (DNLI)
TipRanks · 6d ago
More
Webull provides a variety of real-time HAE stock news. You can receive the latest news about Haemonetics Corp Mass through multiple platforms. This information may help you make smarter investment decisions.
About HAE
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.